We often write about valuation because we believe it is one of the most misunderstood aspects of investing in common stocks. This causes many people to hold what we consider to be unjustified biases that are based primarily on price action. For example, the concept of the lost decade, which many almost gleefully point to as evidence validating that stocks are poor investments, fail to recognize that the true culprit was overvaluation during the appropriately labeled “irrational exuberance” days.
However, one of the most misunderstood aspects of overvaluation is how wide ranging and relative it is. To clarify, one company can technically be labeled overvalued, but due to other important factors, still be a good investment or even an above-average investment. It all comes down to the degree of overvaluation the market is applying, relative to the potential long-term growth the business is capable of achieving.
Starbucks Corp. (SBUX): Overvalued High Growth
We offer Starbucks Corporation (NASDAQ:SBUX) as an example of a stock that is technically overvalued, but not necessarily a poor long-term investment. First of all, by looking at the earnings and price correlated F.A.S.T. Graphs™ below, we discover that the market has historically placed a high valuation on this high-quality growth stock that has only recently morphed into a fast growing dividend growth stock. Consequently, even though you would have had to overpay to invest in the stock, as a long-term owner you would have made good money. The reason for this is simple; strong earnings growth would have bailed you out.
As a long-term shareholder of Starbucks Corporation (NASDAQ:SBUX) your total annual return would have been over six times more than you could have earned in the market as represented by the S&P 500. Keep in mind that although you would have technically been investing in an overvalued stock in 1999, strong earnings growth overcame high valuation in the long run.
The following estimated earnings and return calculator based on the consensus of 28 analysts reporting to Standard & Poor’s Capital IQ tells a very interesting story, assuming of course it turns out to be a true story. Currently, Starbucks trades at a PE ratio above 25; however, the company’s 5-year forecast growth rate is estimated at 18%.
Now here’s the interesting part. The 5-year estimated total return of 13.2% per annum (including dividends) assumes that the Company achieves the 18% growth rate, but also assumes that the future price earnings ratio falls to its earnings justified PE of 18 from its current 25. Therefore, this simple calculation shows that this company could produce a double-digit annualized long-term rate of return as long as earnings grew 18%, and even though the PE ratio contracts to 18.
The point is that a 13% compounded annual return is very healthy, and one that we dare say would be enthusiastically embraced by most investors. Theoretically, the real risk here is that Starbucks Corporation (NASDAQ:SBUX)’s stock price would fall to the orange line over the short run. In other words, there is a potential short-term opportunity cost of buying it today. That opportunity cost could be that it’s possible that you could wait a few weeks or so, and be able to pick up shares at their intrinsic value of $35-$38 per share, compared to today’s current price of $45.87. On the other hand, if this doesn’t occur and the stock continues to rise, you have missed the opportunity of owning.
In summary, Starbucks is a company that is technically overvalued today, but has been overvalued through most of its recent history. Nevertheless, it has generated excellent long-term returns for shareholders exercising the intelligent patience to hold on as long as its fundamentals remained intact. On the other hand, we would argue that the great returns that Starbucks generated were achieved at a higher risk level than a more rational market would have facilitated.
Colgate-Palmolive Co. (CL): Overvalued Moderate Growth
Our second example reviews Colgate-Palmolive Company (NYSE:CL), a moderately fast-growing blue-chip Dividend Champion with a legacy of premium valuation. A quick glance at the earnings and price correlated F.A.S.T. Graphs™ shows that the market typically values this blue-chip above its orange earnings justified valuation line. On the other hand, thanks to the great recession and once again in 2010, there were two times in recent history where Colgate-Palmolive Company (NYSE:CL) could have been purchased at what technically would be called intrinsic value (where the price touches the orange line). Clearly, both of those situations would have been ideal times to invest in Colgate-Palmolive Company (NYSE:CL).
From a performance point of view, even when Colgate is purchased when it is overvalued, its above-average growth rate and consistency, coupled with its steadily increasing dividend, adequately rewarded shareholders. The question the investor has to ask themselves is, are they willing to take the overvaluation risk to own this blue-chip dividend growth star?
Colgate-Palmolive appears to, once again, being awarded its traditional premium valuation by Mr. Market. Nevertheless, including dividends, long-term shareholders would stand to earn an annual return of 6.4% per annum. Keep in mind that this return assumes that the company grows its earnings by the 9% consensus estimate, but also that the PE ratio rationally contracts from its current 23 PE to a fair value PE of 15. On the other hand, if the current PE ratio were to hold, shareholders could achieve a return in excess of 9% per annum. Once again, as an investor you must ask yourself are you willing to take this level of valuation risk to earn those potential rates of return from this blue-chip dividend growth star.
When Overvaluation Becomes Long-term Dangerous
Thus far, we have shown examples where stocks were technically overvalued, but not dangerously so. With our first two examples the real risk was that stock price could temporarily fall to fair value before it advanced long term based on its earnings growth potential. From our perspective, we believe this kind of overvaluation simply means taking a higher risk than is rational, in order to earn a rate of return that is less than fundamentals justify. This implies that it would be possible to find alternative companies with similar fundamentals that could be purchased at more rational valuations.
With our next examples we will illustrate overvaluation situations that were long-term devastating. In addition to providing a vivid and quintessential picture of overvaluation and a true bubble, we are also provided with incontrovertible evidence that the stock market is not always sufficient. In other words, it would be nothing short of absurd to try to argue that the market was correctly pricing EMC Corporation (NYSE:EMC) during the timeframe 1999 -2002. A quick glance at the earnings and price correlated graphic on EMC Corporation (NYSE:EMC) defines the term “irrational exuberance.”
Although EMC Corporation (NYSE:EMC) was technically overvalued in 1997 and 1998, valuation went to the extreme in 1999 and 2000. Therefore, any purchases of the stock in 1998, 1999, 2000, 2001 or 2002 proved disastrous both in the short run and the longer run. Unlike the moderate overvaluation we looked at previously, this dangerous overvaluation would have resulted in significant long-term losses. The point is that, as previously postulated, valuation is a relative thing. Clearly, and admittedly a